Two possible pathways for acquisition of mutations related to nelfinavir resistance.
Sugiura
W
W
AIDS Research Center, National Institute of Infectious Diseases, Tokyo. wsugiura@nih.go.jp
Oishi
T
T
Okano
A
A
Matsuda
M
M
Abumi
H
H
Yamada
K
K
Koike
M
M
Taki
M
M
Ishikawa
M
M
Miura
T
T
Fukutake
K
K
Gouchi
K
K
Ajisawa
A
A
Iwamoto
A
A
Hanabusa
H
H
Mimaya
J
J
Takamatsu
J
J
Takata
N
N
Kakishita
E
E
Higasa
S
S
Kashiwagi
S
S
Shirahata
A
A
Nagai
Y
Y
D004352:Drug Resistance, Microbial / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009154:Mutation; D019888:Nelfinavir / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use; D019258:Saquinavir / Q000627:therapeutic use
D017320:HIV Protease Inhibitors; D019888:Nelfinavir; D019258:Saquinavir; D019438:Ritonavir